MacroGenics, Inc. (MGNX): Price and Financial Metrics
MGNX Price/Volume Stats
| Current price | $1.78 | 52-week high | $5.77 |
| Prev. close | $1.45 | 52-week low | $0.99 |
| Day low | $1.49 | Volume | 1,910,300 |
| Day high | $1.86 | Avg. volume | 666,231 |
| 50-day MA | $1.45 | Dividend yield | N/A |
| 200-day MA | $2.77 | Market Cap | 112.30M |
MGNX Stock Price Chart Interactive Chart >
MacroGenics, Inc. (MGNX) Company Bio
Macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company was founded in 2000 and is based in Rockville, Maryland.
MGNX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MGNX Price Returns
| 1-mo | 15.58% |
| 3-mo | -21.59% |
| 6-mo | -48.85% |
| 1-year | -60.71% |
| 3-year | -46.22% |
| 5-year | -91.13% |
| YTD | -45.23% |
| 2024 | -66.22% |
| 2023 | 43.37% |
| 2022 | -58.19% |
| 2021 | -29.79% |
| 2020 | 110.11% |